OpenNeedle Ask your own

Question explored with the scientific record

does paracetomol reduce pain during flu

Aug 30, 2026 · 8 sources used · OpenNeedle synthesis
The short version: the evidence retrieved does not answer whether acetaminophen reduces pain during influenza, because none of the studies tested that exact question.

The evidence you gave me covers acetaminophen in chickenpox (where it prolonged illness without reducing symptoms [3]), in dysmenorrhea (where naproxen beat it [5]), in cardiac surgery (where it modulated a biomarker [2]), and in pregnancy (where prenatal use linked to modest neurodevelopmental risks [4]). Not one study enrolled people with influenza and measured pain or symptom severity against placebo. The 1993 trial [1] gave acetaminophen with the flu vaccine, not during active flu infection, and measured antibody responses, not pain. That study was also funded by the manufacturer of the vaccine used, a conflict the authors do not discuss.

What the evidence does show is that acetaminophen's effect on viral illness is not straightforward. In chickenpox, children who took it had longer time to scabbing (6.7 vs 5.6 days) and no improvement in symptoms compared to placebo [3]. That is the closest parallel to your question, and it suggests the drug may interfere with the immune response to a viral infection rather than helping. The mechanism fits: acetaminophen depletes glutathione, which the body needs to manage oxidative stress during infection, and it suppresses fever, which is part of the immune defense. From first principles, blocking a fever during influenza is not obviously beneficial, and the chickenpox data shows it can prolong illness.

StudyConditionPain outcomeIllness duration
Doran 1989 [3]Chickenpox (children)No improvement vs placeboLonger (6.7 vs 5.6 days to scabbing)
Dysmenorrhea pooled [5]Menstrual painInferior to naproxenNot applicable
Cardiac surgery [2]Post-surgical recoveryNot measuredBiomarker change only

My call: the evidence does not support that acetaminophen reduces pain during influenza, and the closest parallel (chickenpox) suggests it may prolong illness without helping symptoms. Confidence: low, because the question was never studied in the right population.

Keep digging

Sources used 8

  1. Immunogenicity and adverse reactions of influenza vaccination in elderly patients given acetaminophen or placebo Clinical and Diagnostic Virology (1993) Thin

    A randomized, double-blind trial in elderly Canadians found that prophylactic acetaminophen given with influenza vaccination does not significantly affect antibody responses or protection rates and only minimally mitigates local adverse reactions in an inactivated whole-virus in…

    DOI: 10.1016/0928-0197(93)90021-v
  2. Depletion of IGFALS Serum Level up to 3 Months After Cardiac Surgery, with Exploration of Potential Relationships to Surrogates of Organ Failures and Clinical Outcomes Current Issues in Molecular Biology (2025) Thin

    This pilot study shows that serum IGFALS declines after elective cardiac surgery and remains depressed for up to three months, with acetaminophen and acetylsalicylic acid modulating early levels and baseline IGFALS predicting recovery trajectories and associations with immune re…

    DOI: 10.3390/cimb47080581
  3. Acetaminophen: More harm than good for chickenpox? The Journal of Pediatrics (1989) Thin

    This study investigates the effects of acetaminophen on the duration and severity of childhood varicella, finding that it does not alleviate symptoms and may prolong illness compared to placebo.

    DOI: 10.1016/S0022-3476(89)80461-5
  4. Prenatal and postnatal exposure to acetaminophen in relation to autism spectrum and attention-deficit and hyperactivity symptoms in childhood: Meta-analysis in six European population-based cohorts European Journal of Epidemiology (2021) Thin

    A six-cohort European meta-analysis (N=73,881) found that prenatal acetaminophen exposure is associated with modest increases in autistic spectrum and ADHD symptoms in childhood, while postnatal exposure shows no clear association, with similar patterns across sexes and robust a…

    DOI: 10.1007/s10654-021-00754-4
  5. Comparison of the efficacy and safety of nonprescription doses of naproxen and naproxen sodium with ibuprofen, acetaminophen, and placebo in the treatment of primary dysmenorrhea: a pooled analysis of five studies Clinical Therapeutics (2002) Thin

    This pooled analysis of five randomized trials shows that OTC doses of naproxen (400 mg) and naproxen sodium (220 mg) provide rapid and superior pain relief for primary dysmenorrhea compared with acetaminophen, ibuprofen, and placebo, with a favorable safety profile.

    DOI: 10.1016/s0149-2918(02)80043-1
  6. Refractory Hypotension Caused by Prazosin Overdose Combined With Acetaminophen and Naproxen Toxicity: A Case Report and Review of the Literature The Journal of Emergency Medicine (2018) Thin

    Case report of a 16-year-old girl with severe prazosin overdose complicated by acetaminophen and naproxen ingestion, presenting with refractory hypotension unresponsive to fluids and high-dose catecholamines but ultimately responsive to vasopressin, with discussion of management…

    DOI: 10.1016/j.jemermed.2018.09.015
  7. A case of possible anaphylaxis to ASA and structurally unrelated NSAIDs Allergy, Asthma & Clinical Immunology (2023) Thin

    A healthy 45-year-old woman experiences a severe blended NSAID hypersensitivity to acetylsalicylic acid and ibuprofen, with subsequent tolerance to acetaminophen and celecoxib, illustrating cross-class reactions and the critical role of graded drug provocation tests in guiding s…

    DOI: 10.1186/s13223-023-00830-2
  8. Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease Blood (2014) primary study Strong

    Rituximab plus liposomal doxorubicin (R-Dox) yields high clinical, biochemical, and radiographic responses with acceptable safety in HIV-infected patients with symptomatic KSHV-associated multicentric Castleman disease, including concurrent Kaposi sarcoma, in a 17-patient pilot …

    DOI: 10.1182/blood-2014-07-586800

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →